Harry Perkins Institute of Medical Research is opening the doors today to the ACRF Cancer Imaging Facility, a state of the art imaging centre that has been outfitted with cutting edge technology to enable further breakthroughs in cancer research.
The facility was funded in part by the late Mr Kevin McCusker who made a generous donation to the Australian Cancer Research Foundation through his Will. Mr McCusker was a quiet and unassuming man of strong principles who made this bequest in honour of all the people he loved and lost to cancer.
As a state facility, the equipment will be made available to researchers from all over Western Australia. What this means for cancer patients is that for the first time in WA, researchers will be able to subject cancerous tumours to more intensive scrutiny, and thereby speed up the development of new therapeutic advances.
“Imaging for cancer management and diagnosis in humans is fundamental. These micro-scanners will allow Perkins researchers to image cancer progression in a range of well-developed preclinical models like never before, enabling them to monitor for the first time tumour development, angiogenesis (the process through which new blood vessels form from pre-existing vessels), metastasis (or growth) and response to treatments” says Peter Leedman, Director of the Harry Perkins Institute of Medical Research.
Harry Perkins sees ACRF is absolutely essential in filling a gap that no other foundation fills, which is providing funds for core infrastructure.
“Large cutting-edge pieces of equipment such as the ones at this new facility are remarkably difficult to get in any other way. The ACRF stands alone in this country so we are very grateful to have been able to work with them to attain this final result. It’s allowed us to take an exciting step forward in our field,” says Mr. Leedman.
The Harry Perkins Institute of Medical Research has received $3.6 million in grants from the ACRF which has funded technology to progress research in Leukaemia, breast, prostate, cervical, pancreatic, liver, brain, lung, colon as well as head and neck cancers.